Bilirubin and colorectal cancer [1]

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 10, 2006, Pages 1503-1504

  Vitek, L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ALCOHOL CONSUMPTION; BILIRUBIN BLOOD LEVEL; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; HUMAN; LETTER; LIVER FUNCTION TEST; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; ALCOHOL DRINKING; BILIRUBIN; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33750435230     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03123.x     Document Type: Letter

References (10)

1. Ioannou GN, Liou IW, Weiss NS. Serum bilirubin and colorectal risk: a population-based cohort study. Aliment Pharmacol Ther 2006; 23: 1637-42.
2. Kaerlev L, Lynge E, Sabroe S, Olsen J. Colon cancer controls versus population controls in case-control studies of occupational risk factors. BMC Cancer 2004; 4: 15.
3. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999; 91: 916-32.
4. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875-83.
5. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107: 28-36.
6. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82.
7. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006 Jul 11; [Epub ahead of print].
8. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2006 May 6; [Epub ahead of print].
9. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006; 43: 1145-51.
10. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228: 568-71.